收费全文 | 179504篇 |
免费 | 33414篇 |
国内免费 | 2489篇 |
耳鼻咽喉 | 5426篇 |
儿科学 | 6118篇 |
妇产科学 | 3022篇 |
基础医学 | 6835篇 |
口腔科学 | 2508篇 |
临床医学 | 29604篇 |
内科学 | 52770篇 |
皮肤病学 | 7810篇 |
神经病学 | 17776篇 |
特种医学 | 7489篇 |
外科学 | 44094篇 |
综合类 | 541篇 |
现状与发展 | 72篇 |
一般理论 | 32篇 |
预防医学 | 9948篇 |
眼科学 | 4051篇 |
药学 | 3485篇 |
中国医学 | 50篇 |
肿瘤学 | 13776篇 |
2024年 | 690篇 |
2023年 | 4869篇 |
2022年 | 1351篇 |
2021年 | 3439篇 |
2020年 | 6258篇 |
2019年 | 2579篇 |
2018年 | 7838篇 |
2017年 | 7703篇 |
2016年 | 8796篇 |
2015年 | 8888篇 |
2014年 | 16210篇 |
2013年 | 16872篇 |
2012年 | 7342篇 |
2011年 | 7487篇 |
2010年 | 11411篇 |
2009年 | 15288篇 |
2008年 | 7740篇 |
2007年 | 6188篇 |
2006年 | 8656篇 |
2005年 | 5854篇 |
2004年 | 5096篇 |
2003年 | 3975篇 |
2002年 | 4019篇 |
2001年 | 4086篇 |
2000年 | 3211篇 |
1999年 | 3506篇 |
1998年 | 4041篇 |
1997年 | 3793篇 |
1996年 | 3653篇 |
1995年 | 3473篇 |
1994年 | 2189篇 |
1993年 | 1815篇 |
1992年 | 1538篇 |
1991年 | 1603篇 |
1990年 | 1210篇 |
1989年 | 1327篇 |
1988年 | 1149篇 |
1987年 | 1000篇 |
1986年 | 1010篇 |
1985年 | 882篇 |
1984年 | 760篇 |
1983年 | 679篇 |
1982年 | 751篇 |
1981年 | 639篇 |
1980年 | 591篇 |
1979年 | 429篇 |
1978年 | 444篇 |
1977年 | 506篇 |
1975年 | 344篇 |
1972年 | 332篇 |
Methods. Twenty patients less than 15 kg were studied. Cardiopulmonary bypass circuits were primed with crystalloid solutions. Red blood cells were added during cardiopulmonary bypass for hematocrits less than 15%. Colloid solutions were not administered. Concentrations of fibrinogen, plasma proteins, and platelets, and hematocrit were measured before cardiopulmonary bypass, before modified ultrafiltration, and after modified ultrafiltration.
Results. Modified ultrafiltration was associated with significant (p < 0.001) increases in hematocrit (19% ± 6% to 31% ± 9%), fibrinogen (65 ± 29 to 101 ± 45 mg/dL), and total plasma proteins (2.7 ± 0.3 to 4.9 ± 0.7 g/dL), but no change (p = 0.129) in platelet count.
Conclusions. We conclude that modified ultrafiltration significantly attenuates the dilutional coagulopathy associated with cardiopulmonary bypass in infants. 相似文献
Methods. From January 1989 to January 1996, 37 patients with renal cell carcinoma and inferior vena cava tumor thrombus underwent surgical resection. The 27 men and 10 women had a median age of 57 years (range, 29 to 78 years). Thirty-six patients presented with symptoms; 21 had hematuria. Distant metastases were present in 12 patients. Tumor thrombi extended to the infrahepatic inferior vena cava (n = 16), the intrahepatic inferior vena cava (n = 16), the suprahepatic inferior vena cava (n = 3), and into the right atrium (n = 2). All tumors were resected by inferior vena cava isolation and, when necessary, extended hepatic mobilization and Pringle maneuver, with primary or patch closure of the vena cavotomy. Cardiopulmonary bypass was necessary in only 2 patients with intraatrial thrombus.
Results. Complications occurred in 11 patients, and 1 patient died 2 days postoperatively of a myocardial infarction (mortality, 2.7%). Twenty patients are alive; overall 2- and 5-year survival rates were 61.7% and 33.6%, respectively. For patients without lymph node or distant metastases (stage IIIa), 2- and 5-year survival rates were 74% and 45%, respectively. The presence of distant metastatic disease (stage IV) at the time of operation did not have a significant adverse effect on survival, as reflected by 2- and 5-year survival rates of 62.5% and 31.3%, respectively. Lymph node metastases (stage IIIc) adversely affected survival as there were no long-term survivors.
Conclusions. Resection of an intracaval tumor thrombus arising from renal cell carcinoma can be performed safely and can result in prolonged survival even in the presence of metastatic disease. In our experience, extracorporeal circulatory support was required only when the tumor thrombus extended into the heart. 相似文献